AIM ImmunoTech Inc [AIM] stock prices are up 8.00% to $0.41 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The AIM shares have gain 14.08% over the last week, with a monthly amount glided 6.86%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 15, March 2024, AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity. In a post published today on Yahoo Finance, Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, March 20th at 12:00 PM ET.
From an analyst’s perspective:
The stock price of AIM ImmunoTech Inc [AIM] has been fluctuating between $0.32 and $0.75 over the past year. AIM ImmunoTech Inc [AMEX: AIM] shares were valued at $0.41 at the most recent close of the market.
Analyzing the AIM fundamentals
The AIM ImmunoTech Inc [AMEX:AIM] reported sales of 0.19M for trailing twelve months, representing a surge of 119.05%. Gross Profit Margin for this corporation currently stands at -102.53% with Operating Profit Margin at -119.83%, Pretax Profit Margin comes in at -107.64%, and Net Profit Margin reading is -102.94%. To continue investigating profitability, this company’s Return on Assets is posted at -0.71, Equity is -0.63 and Total Capital is -1.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3766 points at the first support level, and at 0.3482 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4368, and for the 2nd resistance point, it is at 0.4686.
AIM ImmunoTech Inc [AIM] reported earnings per share of -$0.16 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.11/share, meaning a difference of -$0.05 and a surprise factor of -45.50%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.1 per share as compared to estimates of -$0.11 per share, a difference of $0.01 representing a surprise of 9.10%.
Ratios To Look Out For
It’s worth pointing out that AIM ImmunoTech Inc [AMEX:AIM]’s Current Ratio is 4.82. On the other hand, the Quick Ratio is 4.82, and the Cash Ratio is 3.24. Considering the valuation of this stock, the price to sales ratio is 104.11, the price to book ratio is 0.90.
Transactions by insiders
Recent insider trading involved APPELROUTH STEWART, Director, that happened on Mar 15 ’24 when 90910.0 shares were purchased. CEO & President, Equels Thomas K completed a deal on Mar 15 ’24 to buy 75758.0 shares. Meanwhile, COO, Secretary, Gen. Counsel Rodino Peter W III bought 37879.0 shares on Mar 15 ’24.
